WHO ICTRP trial
Study of new compounds in the treatment of brain tumors: drug levels and signs…
EUCTR2016-004471-46-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-004471-46-SE |
|---|---|
| Public title | Study of new compounds in the treatment of brain tumors: drug levels and signs of effect inside the tumor tissue (INSIDE) |
| Scientific title | Drug level and Investigation of Novel Substances Indicated Downstream Effect in (INSIDE) glioblastoma - INSIDE |
| Primary sponsor | Sahlgrenska University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Sweden |
| Conditions | Glioblastoma MedDRA version: 19.1 Level: PT Classification code 10018336 Term: Glioblastoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04] |
| Interventions | Trade Name: Antabus Pharmaceutical Form: Effervescent tablet INN or Proposed INN: DISULFIRAM CAS Number: 97-77-8 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 200- Trade Name: Metformin Actavis… |
| Registration date | Nov 1, 2017 |
| Target size | 40 |
| Secondary IDs | INSIDE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: